Evidence map›Paper›PMID 36933174›Full record

ArticleAngiogenesis2023

The vascular gene Apold1 is dispensable for normal development but controls angiogenesis under pathological conditions.

Zheng Fan, Raphaela Ardicoglu, Aashil A Batavia, Ruslan Rust, Lukas von Ziegler, Rebecca Waag, Jing Zhang, Thibaut Desgeorges, Oliver Sturman, Hairuo Dang and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Angiogenesis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Zheng Fan *Department of Health Sciences and Technology, Laboratory of Exercise and Health, ETH Zürich, Zurich, Switzerland.
Raphaela Ardicoglu *Department of Health Sciences and Technology, Laboratory of Exercise and Health, ETH Zürich, Zurich, Switzerland.
Aashil A BataviaDepartment of Pathology and Molecular Pathology, University and University Hospital Zürich, Zurich, Switzerland.
Ruslan RustDepartment of Health Sciences and Technology, Institute for Regenerative Medicine, University of Zürich, ETH Zürich, Zurich, Switzerland.
Lukas von ZieglerDepartment of Health Sciences and Technology, Laboratory of Molecular and Behavioral Neuroscience, Institute for Neuroscience, ETH Zürich, Zurich, Switzerland.
Rebecca WaagDepartment of Health Sciences and Technology, Laboratory of Molecular and Behavioral Neuroscience, Institute for Neuroscience, ETH Zürich, Zurich, Switzerland.
Jing ZhangDepartment of Health Sciences and Technology, Laboratory of Exercise and Health, ETH Zürich, Zurich, Switzerland.
Thibaut DesgeorgesDepartment of Health Sciences and Technology, Laboratory of Exercise and Health, ETH Zürich, Zurich, Switzerland.
Oliver SturmanDepartment of Health Sciences and Technology, Laboratory of Molecular and Behavioral Neuroscience, Institute for Neuroscience, ETH Zürich, Zurich, Switzerland.
Hairuo DangDepartment of Health Sciences and Technology, Laboratory of Exercise and Health, ETH Zürich, Zurich, Switzerland.
Rebecca WeberDepartment of Health Sciences and Technology, Institute for Regenerative Medicine, University of Zürich, ETH Zürich, Zurich, Switzerland.
Martin RoszkowskiDepartment of Health Sciences and Technology, Laboratory of Molecular and Behavioral Neuroscience, Institute for Neuroscience, ETH Zürich, Zurich, Switzerland.
Andreas E MoorDepartment of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.
Martin E SchwabDepartment of Health Sciences and Technology, Institute for Regenerative Medicine, University of Zürich, ETH Zürich, Zurich, Switzerland.
Pierre-Luc GermainNeuroscience Center Zurich, ETH Zürich, University of Zürich, Zurich, Switzerland.
Johannes BohacekDepartment of Health Sciences and Technology, Laboratory of Molecular and Behavioral Neuroscience, Institute for Neuroscience, ETH Zürich, Zurich, Switzerland. johannes.bohacek@hest.ethz.ch.
Katrien De BockDepartment of Health Sciences and Technology, Laboratory of Exercise and Health, ETH Zürich, Zurich, Switzerland. katrien-debock@ethz.ch.
ETH Zurich · CHUniversity of Zurich · CHDKFZ-ZMBH Alliance · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The molecular mechanisms of angiogenesis have been intensely studied, but many genes that control endothelial behavior and fate still need to be described. Here, we characterize the role of Apold1 (Apolipoprotein L domain containing 1) in angiogenesis in vivo and in vitro. Single-cell analyses reveal that - across tissues - the expression of Apold1 is restricted to the vasculature and that Apold1 expression in endothelial cells (ECs) is highly sensitive to environmental factors. Using Apold1

Indexed as

Endothelial CellsNeovascularization, PhysiologicAnimalsHindlimbHumansHypoxiaImmediate-Early ProteinsIschemiaMiceMice, Inbred C57BLMice, KnockoutApold1 protein, mouseImmediate-Early ProteinsAngiogenesisEC proliferationEndothelial cellHindlimb ischemiaStrokeTumor

Identifiers

PMID36933174
PMCPMC10328887
OpenAlexW4327811329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.